|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Eloxx Pharmaceuticals Inc. (ELOX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-05-22 Purchase |
2018-05-23 4:17 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
5,000 | $14.34 | $71,700 | 15,000 (Direct) |
View |
| 2018-04-30 Purchase |
2018-05-01 4:39 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Shabtai Gilad 10% Owner |
75,000 | $9.75 | $731,250 | 3,351,770 (Direct) |
View |
| 2018-04-30 Purchase |
2018-05-01 4:37 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
350,000 | $9.75 | $3,412,500 | 962,504 (Indirect) |
View |
| 2018-04-30 Purchase |
2018-05-01 4:34 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
350,000 | $9.75 | $3,412,500 | 4,900,249 (Indirect) |
View |
| 2018-04-30 Purchase |
2018-05-01 4:32 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director |
300,000 | $9.75 | $2,925,000 | 2,953,673 (Indirect) |
View |
| 2018-04-30 Purchase |
2018-05-01 4:31 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
350,000 | $9.75 | $3,412,500 | 4,900,249 (Indirect) |
View |
| 2018-04-03 Purchase |
2018-04-05 6:08 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Shabtai Gilad 10% Owner |
8,300 | $9.463 | $78,545 | 3,276,770 (Direct) |
View |
| 2018-03-29 Purchase |
2018-04-02 5:43 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Shabtai Gilad 10% Owner |
4,500 | $9.64 | $43,380 | 3,268,470 (Direct) |
View |
| 2018-03-26 Purchase |
2018-03-28 4:37 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
2,000 | $9.49 | $18,980 | 2,263 (Indirect) |
View |
| 2018-03-23 Purchase |
2018-03-26 5:13 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO |
10,000 | $8.99 | $89,900 | 10,000 (Direct) |
View |
| 2018-03-23 Purchase |
2018-03-26 5:11 pm |
Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO |
4,500 | $8.56 | $38,520 | 4,500 (Direct) |
View |
| 2018-03-21 Purchase |
2018-03-23 4:20 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
12,600 | $7.764 | $97,830 | 4,900,249 (Indirect) |
View |
| 2018-03-21 Purchase |
2018-03-23 4:18 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
12,600 | $7.764 | $97,830 | 4,900,249 (Indirect) |
View |
| 2018-03-21 Purchase |
2018-03-23 4:16 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
12,600 | $7.764 | $97,830 | 789,878 (Indirect) |
View |
| 2018-03-21 Purchase |
2018-03-22 7:18 pm |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
263 | $7.6 | $1,999 | 263 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-06-06 Exercise |
2018-06-29 4:12 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
349,400 | $0.0006 | 490,789 (Direct) |
View |
| 2018-06-06 Exercise |
2018-06-29 4:12 pm |
N/A 2024-04-26 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
349,400 | $0.0006 | 490,789 (Direct) |
View |
| 2018-06-25 Option Award |
2018-06-26 8:53 pm |
N/A 2028-06-25 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO |
300,000 | $18.84 | 300,000 (Direct) |
View |
| 2018-06-25 Option Award |
2018-06-26 8:52 pm |
N/A 2028-06-25 |
Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. Chief Business Officer |
200,000 | $18.85 | 200,000 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 5:34 pm |
N/A 2028-06-18 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. General Counsel and Secretary |
125,000 | $20.85 | 125,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 9:31 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:27 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:26 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:24 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:22 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:22 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:19 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:19 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
40,000 | $23.27 | 40,000 (Indirect) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:17 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
141,389 | $0 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
2018-06-15 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
141,389 | $23.27 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:15 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia CEO |
40,000 | $23.27 | 141,389 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:12 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 6:08 pm |
N/A 2028-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
40,000 | $23.27 | 40,000 (Direct) |
View |
| 2018-05-16 Option Award |
2018-05-18 08:05 am |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Huertas Pedro Chief Medical Officer |
33,000 | $0 | 137,725 (Direct) |
View |
| 2018-05-10 Option Award |
2018-05-11 4:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Huertas Pedro Chief Medical Officer |
104,725 | $0 | 104,725 (Direct) |
View |
| 2018-05-10 Option Award |
2018-05-11 4:05 pm |
N/A 2028-05-10 |
Eloxx Pharmaceuticals Inc. | ELOX | Huertas Pedro Chief Medical Officer |
104,725 | $14.88 | 104,725 (Direct) |
View |
| 2017-12-20 Option Award |
2018-02-23 4:17 pm |
N/A 2027-12-19 |
Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO |
399,266 | $6 | 399,266 (Direct) |
View |
| 2018-01-15 Option Award |
2018-01-22 09:25 am |
N/A 2028-01-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Huertas Pedro Chief Medical Officer |
50,000 | $6.65 | 50,000 (Direct) |
View |
| 2017-12-26 Option Award |
2017-12-28 4:46 pm |
N/A 2027-12-26 |
Eloxx Pharmaceuticals Inc. | SVOND | Ward Robert CEO |
22,427 | $0 | 640,785 (Direct) |
View |
| 2017-12-26 Option Award |
2017-12-28 4:46 pm |
N/A 2027-12-26 |
Eloxx Pharmaceuticals Inc. | SVOND | Ward Robert CEO |
22,427 | $8 | 640,785 (Direct) |
View |
| 2017-12-26 Option Award |
2017-12-28 4:46 pm |
N/A 2027-12-26 |
Eloxx Pharmaceuticals Inc. | SVOND | Ward Robert CEO |
640,785 | $0 | 640,785 (Direct) |
View |
| 2017-12-26 Option Award |
2017-12-28 4:46 pm |
N/A 2027-12-26 |
Eloxx Pharmaceuticals Inc. | SVOND | Ward Robert CEO |
640,785 | $8 | 640,785 (Direct) |
View |
| 2017-12-20 Option Award |
2017-12-22 2:50 pm |
N/A 2027-12-20 |
Eloxx Pharmaceuticals Inc. | SVON | WEAVER GREGORY L CFO |
399,266 | $7 | 399,266 (Direct) |
View |
| 2017-12-19 Option Award |
2017-12-21 8:19 pm |
2017-12-19 2027-12-19 |
Sevion Therapeutics Inc. | SVOND | RECTOR DAVID See Remarks |
27,500 | $6 | 27,500 (Direct) |
View |
| 2017-12-19 Option Award |
2017-12-21 8:18 pm |
2017-12-19 2027-12-19 |
Sevion Therapeutics Inc. | SVOND | BRACA JOHN N See Remarks |
18,190 | $6 | 18,190 (Direct) |
View |
| 2017-12-19 Option Award |
2017-12-21 8:18 pm |
2017-12-19 2027-12-19 |
Sevion Therapeutics Inc. | SVOND | FROST PHILLIP MD See Remarks |
3,621 | $6 | 3,621 (Direct) |
View |
| 2017-12-19 Option Award |
2017-12-21 8:17 pm |
2017-12-19 2027-12-19 |
Sevion Therapeutics Inc. | SVOND | Rubin Steven D Director |
43,189 | $6 | 43,189 (Direct) |
View |
| 2017-12-19 Option Award |
2017-12-21 6:27 pm |
N/A N/A |
Sevion Therapeutics Inc. | SVOND | Opko Health Inc. 10% Owner |
495,126 | $0 | 1,289,818 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Fri, 17 Aug 2018 10:08:57 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |